Outcomes and risk factors of late failure of valve-sparing aortic root replacement.


Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
08 2022
Historique:
received: 10 01 2020
revised: 18 08 2020
accepted: 09 09 2020
pubmed: 21 10 2020
medline: 20 7 2022
entrez: 20 10 2020
Statut: ppublish

Résumé

Retention of the native aortic valve when performing aortic root surgery for aneurysmal disease has become a more common priority. We reviewed our experience in valve-sparing aortic root replacement (VSARR) to evaluate the long-term outcomes and the risk factors for reoperation. From January 1994 through June 2017, 342 patients (mean age 47.8 ± 15.5 years, 253 [74%] male) underwent VSARR. The most common etiologies were connective tissue disease (n = 143, 42%) followed by degenerative aortic aneurysm (n = 131, 38%). Aortic regurgitation (moderate or greater) was present in 35% (n = 119). Reimplantation technique was used in 90% patients (n = 308). Valsalva graft was used in 38% patients (n = 131) and additional cusp repair was done in 15% (n = 50). Operative mortality was 1% (n = 5). The median follow-up time was 8.79 years (interquartile range, 4.08-13.51). The cumulative incidence of reoperation (while accounting for the competing risk of death) was 8.4%, 12.8%, and 17.1% at 5, 10, and 15 years, respectively. There were no differences in survival and incidence of reoperation between root reimplantation and remodeling. Larger preoperative annulus diameter was associated with greater risk of reoperation (hazard ratio, 1.10; 95% confidence interval, 1.02-1.19, P = .01). The estimated probability of developing severe aortic regurgitation after VSARR was 8% at 10 years postoperatively. Operative mortality, residual aortic regurgitation at dismissal, and survival improved in recent times with more experience. VSARR is a viable and safe option with good long-term outcomes and low rates of late aortic valve replacement. Dilated annulus preoperatively was associated with early repair failure.

Identifiants

pubmed: 33077178
pii: S0022-5223(20)32668-4
doi: 10.1016/j.jtcvs.2020.09.070
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

493-501.e1

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Sri Harsha Patlolla (SH)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.

Nishant Saran (N)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn. Electronic address: Saran.nishant@mayo.edu.

Joseph A Dearani (JA)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.

John M Stulak (JM)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.

Hartzell V Schaff (HV)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.

Kevin L Greason (KL)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.

Richard C Daly (RC)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.

Katherine S King (KS)

Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minn.

Alberto B Pochettino (AB)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH